Tag: psychedelic therapy

Researchers at the University of Southern California will investigate whether mindfulness meditation can improve the effects of psilocybin-assisted therapy for ...

New Mexico is continuing work on the regulatory framework for a medical psilocybin programme, with proposed rules covering the people, ...

Emyria has begun treating its first patients at a new Sydney clinic, extending its Empax mental health services into New ...

Australian psychedelic medicine company Emyria has brought former US Secretary of Veterans Affairs Dr David Shulkin into its strategy as ...

For much of the past decade, the psychedelic industry has revolved around companies developing the drugs themselves. Psilocybin, MDMA, LSD ...

Australian psychedelic medicine company Emyria Limited (ASX: EMD) has been selected by the US Food and Drug Administration (FDA) to ...

New Zealand has authorised two psychiatrists to prescribe pharmaceutical-grade MDMA as part of supervised treatment for adults with post-traumatic stress ...

Ensysce Biosciences will participate in the U.S. Food and Drug Administration's September 14 public hearing on the potential future therapeutic ...

Psychedelic medicine has spent the past decade developing clinical evidence almost exclusively in adults. Adolescents have largely remained outside the ...

New Zealand is building a small but increasingly active psychedelic medicine sector, with clinical psilocybin access, Māori-led research and a ...